Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes.
Pareja F, Bhargava R, Borges VF, Brogi E, Canas Marques R, Cardoso F, Desmedt C, Harigopal M, Lakhani SR, Lee A, Leone JP, Linden H, Lord CJ, Marchio C, Merajver SD, Rakha E, Reis-Filho JS, Richardson A, Sawyer E, Schedin P, Schwartz CJ, Tutt A, Ueno NT, Vincent-Salomon A, Weigelt B, Wen YH, Schnitt SJ, Oesterreich S. Pareja F, et al. Among authors: linden h. NPJ Breast Cancer. 2025 Jan 24;11(1):6. doi: 10.1038/s41523-025-00719-w. NPJ Breast Cancer. 2025. PMID: 39856067 Free PMC article. Review.
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial.
Palmieri C, Linden H, Birrell SN, Wheelwright S, Lim E, Schwartzberg LS, Dwyer AR, Hickey TE, Rugo HS, Cobb P, O'Shaughnessy JA, Johnston S, Brufsky A, Tilley WD, Overmoyer B. Palmieri C, et al. Among authors: linden h. Lancet Oncol. 2024 Mar;25(3):317-325. doi: 10.1016/S1470-2045(24)00004-4. Epub 2024 Feb 8. Lancet Oncol. 2024. PMID: 38342115 Free article. Clinical Trial.
Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency.
Stecklein SR, Barlow W, Pusztai L, Timms K, Kennedy R, Logan GE, Seitz R, Badve S, Gökmen-Polar Y, Porter P, Linden H, Tripathy D, Hortobagyi GN, Godwin AK, Thompson A, Hayes DF, Sharma P. Stecklein SR, et al. Among authors: linden h. JCO Precis Oncol. 2023 Sep;7:e2300197. doi: 10.1200/PO.23.00197. JCO Precis Oncol. 2023. PMID: 37972336 Free PMC article.
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer.
Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Linden HH, Livingston RB, Hortobagyi GN. Mehta RS, et al. Among authors: linden hh. N Engl J Med. 2019 Mar 28;380(13):1226-1234. doi: 10.1056/NEJMoa1811714. N Engl J Med. 2019. PMID: 30917258 Free PMC article. Clinical Trial.
Thrombotic microangiopathy following gene therapy for 5q-spinal muscular atrophy.
Camelo CG, Mendonça RH, Moreno CAM, Ferreira JCOA, Ortega AB, van der Linden V, Campos RSM, van der Linden H, da Cunha NSC, Gurgel-Giannetti J, Chaves JM, Miranda SMC, Ziegler A, Zanoteli E. Camelo CG, et al. Among authors: van der linden h. Gene Ther. 2025 Jun 19. doi: 10.1038/s41434-025-00545-6. Online ahead of print. Gene Ther. 2025. PMID: 40533496
[18 F]-Fluoroestradiol PET (FES-PET) and [18 F] Flurodeoxyglucose PET (FDG-PET) Imaging May Aid in Managing Therapy in Patients with Metastatic Lobular Breast Cancer.
Manohar PM, Peterson LM, Jenkins IC, Wu QV, Kurland BF, Novakova-Jiresova A, Muzi M, Chen DL, Specht JM, Dintzis S, Kinahan PE, Mankoff DA, Linden HM. Manohar PM, et al. Among authors: linden hm. Mol Imaging Biol. 2025 Jun;27(3):410-420. doi: 10.1007/s11307-025-02015-2. Epub 2025 May 14. Mol Imaging Biol. 2025. PMID: 40369385 Free PMC article.
Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study.
Escrivá-de-Romani S, Cejalvo JM, Alba E, Friedmann J, Rodríguez-Lescure Á, Savard MF, Pezo RC, Gion M, Ruiz-Borrego M, Hamilton E, Pluard T, Webster M, Beeram M, Linden H, Saura C, Shpektor D, Salim B, Harvey P, Hurvitz SA. Escrivá-de-Romani S, et al. Among authors: linden h. Lancet Oncol. 2025 Jun;26(6):745-758. doi: 10.1016/S1470-2045(25)00140-8. Epub 2025 May 5. Lancet Oncol. 2025. PMID: 40339592 Clinical Trial.
Disease profile in a cohort of Brazilian patients diagnosed with alpha-mannosidosis.
Poswar FO, Alves TS, de Carvalho DR, van der Linden H Jr, Lourenço CM, Horovitz DDG, Barth A, Mendes CSC, Martins AM, Giugliani R. Poswar FO, et al. Among authors: van der linden h jr. Mol Genet Metab Rep. 2025 Apr 11;43:101220. doi: 10.1016/j.ymgmr.2025.101220. eCollection 2025 Jun. Mol Genet Metab Rep. 2025. PMID: 40276561 Free PMC article.
347 results